Please use this identifier to cite or link to this item:
http://hdl.handle.net/123456789/6458
Full metadata record
DC Field | Value | Language |
---|---|---|
dc.contributor.author | McKinsey | - |
dc.date.accessioned | 2020-07-31T03:01:22Z | - |
dc.date.available | 2020-07-31T03:01:22Z | - |
dc.date.issued | 2020-07 | - |
dc.identifier.uri | http://hdl.handle.net/123456789/6458 | - |
dc.language.iso | en | en_US |
dc.publisher | McKinsey | en_US |
dc.subject | Pharmaceuticals & Medical Products | en_US |
dc.subject | Medical Products | en_US |
dc.subject | COVID-19 Crisis | en_US |
dc.title | Creating Value From Next-Generation Realworld Evidence | en_US |
dc.type | Article | en_US |
dc.page | 9Pp | en_US |
Appears in Collections: | Articles |
Files in This Item:
File | Description | Size | Format | |
---|---|---|---|---|
Creating-value-from-next-generation-real-world-evidence.pdf | 333.22 kB | Adobe PDF | View/Open Request a copy |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.